Concepedia

Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients

Domenico Prisco, Cinzia Fatini, B. Battaglini, Francesca Gensini, Sandra Fedi, Massimiliano Falai, Maurizio Chioccioli, Anna Maria Gori, Massimo Margheri, Gianfranco Gensini

International Journal of Clinical & Laboratory Research · 2000 · 12 citations · 31 references

Concepts

ThrombosisPercutaneous Coronary InterventionHypertensionEnzyme Dd GenotypeCardiovascular DiseasePharmacologyCardiologyVascular BiologyMedicineAtherosclerosisAcute Myocardial InfarctionMyocardial Infarction

References

31

The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings

Hiltrud S. Mueller, A. R. DYER, Mark A. Greenberg · 1985 · 3.6K citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +7

The Thrombolysis in Myocardial Infarction (TIMI) Trial

New England Journal of Medicine · 1985 · 3.2K citations

Thrombosis, Cardiovascular Disease, Thrombolytic Therapy +10

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

François Cambien, Odette Poirier, Laure Lecerf et al. · Nature · 1992 · 1.9K citations

Deletion Polymorphism, Epidemiology, Cardiomyopathy +12

Transluminal Treatment of Arteriosclerotic Obstruction

Charles T. Dotter, Melvin P. Judkins · Circulation · 1964 · 1.8K citations · Full text

Limb Reconstruction, Endovascular Technique, Prevent Amputation +12

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

Brigitte Rigat, Christine Hübert, Pierre Corvol et al. · Nucleic Acids Research · 1992 · 1.3K citations · Full text

Engineering, Genetics, Enzyme Gene +7